Compass Therapeutics, Inc. logo

CMPXCompass Therapeutics, Inc.

CMPX Stock Price, Valuation & Chart | Compass Therapeutics, Inc.

Compare

CMPX Historical price chart

CMPX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization437.61M
PE Ratio-6.07
EPS-0.4
Trading Volume2.53M
Today's High/Low2.46/2.31
Dividend Yield0.00
52 Week High/Low6.88/1.61
Shares Outstanding180.09M
CMPX Financial Statement
CMPX Analyst ratings
CMPX Analysis & performance metrics

CMPX Company profile

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases.…

CMPX Management team

Management
Neil L. Lerner CPA
Senior Vice President & Chief Accounting Officer
Thomas J. Schuetz M.D., Ph.D.CEO
Chief Executive Officer & Vice Chairman
Karin Herrera B.A.
Senior Vice President & Head of Clinical Operations
Anna Gifford
Communications Manager
James Kranz Ph.D.
Vice President and Head of Chemistry Manufacturing & Controls
Vered Bisker-Leib MBA, Ph.D.
Advisor
Barry Shin J.D., M.B.A.CFO
Chief Financial Officer
Minori Rosales M.D., Ph.D.
Senior Vice President & Head of Clinical Development
Total 8 executives

CMPX Frequently asked questions

What is Compass Therapeutics, Inc. (CMPX) Stock Price?

Current stock price of Compass Therapeutics, Inc. (CMPX) stock is $2.430. The stock price is +5.19% higher in the session. The intraday range can be seen from this page. Volume of Compass Therapeutics, Inc. (CMPX) stock is 2.53M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Compass Therapeutics, Inc. (CMPX) stock price going up or down today?

The stock price of Compass Therapeutics, Inc. (CMPX) can change with earnings, company news, and overall market sentiment. Compass Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Compass Therapeutics, Inc. stock expensive at its current price?

Whether Compass Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CMPX on this page is -6.07. EPS on this page is -0.40. Compare those figures with peers and growth expectations before deciding if the current Compass Therapeutics, Inc. price is justified.

How has the stock price of Compass Therapeutics, Inc. (CMPX) performed historically?

Historical performance for Compass Therapeutics, Inc. (CMPX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CMPX reacted to past earnings and market events.

Should I buy Compass Therapeutics, Inc. (CMPX) stock, at this price?

Buying Compass Therapeutics, Inc. (CMPX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.